Global Incubator Programme: Houston, USA - Healthtech

Innovate UK Edge are seeking up to 16 innovative digital health and medical device companies for an incubation programme in Houston, USA.

Opportunity Details


Registration Opens


Registration Closes



Innovate UK will fund and organise flights, accommodation, in-market transfers for successful applicants for two group market visits. One representative from each company will be funded per visit. Also includes training, support, mentoring, pitching opportunities, networking opportunities and more.


Innovate UK

Share this opportunity

Innovate UK’s Global Incubator Programme is an acceleration programme for innovative companies to work with world-leading incubators abroad. We are currently accepting applications for up to 16 innovative companies in the digital health and medical device sectors to join our programme. The programmes is delivered in partnership with the Texas Medical Centre (TMC), Houston, USA. The Programme is delivered in partnership with the Texas Medical Centre (TMC), Houston, USA and supported by the Department for Business & Trade (DBT), as part of the UK TMC BioBridge agreement.

We would welcome applications from innovative companies who could be developing technologies across a broad range of Healthtech sectors including (but not limited to):

  • Clinical Decision Support
  • Hospital Efficiency
  • Remote Patient Monitoring
  • Digital Therapeutics
  • Surgical Devices
  • ICU Devices
  • Outpatient Medical Devices
  • AI in Radiology
  • Wearables & Devices that enable Patient Monitoring
  • Diagnostic Platforms
  • Biomaterials

Click here for a flyer with further information.

  • To apply, you must:

    • Be a UK based company
    • Be a business with fewer than 500 employees
    • Have a focus on the healthtech sector

    On acceptance to the initiative a commitment fee of £1000 will be obtained from each delegate, which will be refunded on completion of the full activities and agreed action plan. Non-completion after formal acceptance may result in forfeiting some or all the commitment fee.

  • Why Texas Medical Center?

    Texas Medical Center (TMC) — the
    largest medical complex in the world is at
    the forefront of advancing life sciences.
    Housing the brightest medical minds, its
    50 million sq. ft. campus annually serves
    10 million patients, conducts 180,000+
    surgeries, 750,000 ER visits, 14,000
    heart surgeries, and delivers 25,000+

    The TMC Accelerator offers emerging
    digital health and medical device
    pioneers access to the world’s largest
    medical city. It’s the prime hub for
    international firms, as TMC’s clinical,
    business, and expert insights shape
    market entry, growth, and
    commercialisation strategies.
    Since 2015, TMC has dedicatedly
    supported startups aiming to expand in
    the US.

    Why Houston?

    As a hub for medical device
    manufacturing, pharmaceuticals and
    health research, Houston has more than
    1,760 life sciences companies,
    cutting-edge health care facilities and
    research institutions. The healthcare and
    life sciences industries collectively
    employ 320,500 workers.

  • Applications close: 12th January 2024

    Shortlist Interviews: 4th – 15th March 2024

    Cohort confirmed: 22nd March 2024

    Programme commences: June 2024

    Register to attend the applicant briefing on 5th December 2023 here

    For more information, assistance with your application or to discuss accessibility needs, please contact: Ian Fletcher at or call +44 (0)7572 385533


Connect with Innovate UK Business Connect

Join Innovate UK Business Connect's mailing list to receive updates on funding opportunities, events and to access Innovate UK Business Connect's deep expertise. Please check your email to confirm your subscription and select your area(s) of interest.